Filters close
11-Oct-2024 10:00 AM EDT
In Landmark Study, Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma
University of Rochester Medical Center

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the disease. The New England Journal of Medicine published the innovative clinical trial results this week.

Newswise:Video Embedded turns-out-male-roundworms-are-picky-when-choosing-a-mate-new-research-finds
VIDEO
6-Mar-2024 9:05 AM EST
Turns out—male roundworms are picky when choosing a mate, new research finds
University of Rochester Medical Center

The Portman lab at the Del Monte Institute for Neuroscience at the University of Rochester discovered that the male roundworms use pheromones and touch signals to determine the sex, age, nutritional health, and mating history of the hermaphrodites and show preference toward worms that have not previously mated with another male and are nutritionally healthy.

Newswise: Researchers find possible neuromarker for ‘juvenile-onset’ Batten disease
Released: 8-Jan-2024 3:05 PM EST
Researchers find possible neuromarker for ‘juvenile-onset’ Batten disease
University of Rochester Medical Center

The research suggests an easy-to-measure brain process may be a target or biomarker in measuring treatment outcomes in clinical trials for patients with Batten disease.

Newswise: Researchers identify path to prevent cognitive decline after radiation
Released: 3-Jan-2024 10:05 AM EST
Researchers identify path to prevent cognitive decline after radiation
University of Rochester Medical Center

Researchers at the Del Monte Institute for Neuroscience at the University of Rochester find that microglia—the brain’s immune cells—can trigger cognitive deficits after radiation exposure and may be a key target for preventing these symptoms.

Newswise: Pulling the Plug on Brain Injury
13-Nov-2023 11:00 AM EST
Pulling the Plug on Brain Injury
University of Rochester Medical Center

New research appearing today in the journal Nature shows that a cocktail of drugs already approved to treat high blood pressure quickly reduces brain swelling and improves outcomes in animal models of brain injury.

Released: 25-Sep-2009 9:00 AM EDT
Young Adults Visit Doctors Least at an Age When Risky Behavior Peaks
University of Rochester Medical Center

The prevalence of substance abuse, sexually transmitted diseases, homicide and motor vehicle crashes all peak in young adulthood. Yet the study’s findings show that young adults under use ambulatory medical care, infrequently receive preventive care and rarely receive counseling directed at the greatest threats to their health.

24-Sep-2009 12:40 PM EDT
Viagra Relatives May Shrink Abnormally Large Hearts
University of Rochester Medical Center

Compounds related to Viagra, which is already in clinical trials to prevent heart failure, may also counter the disease in a different way, according to a study published online today in the journal Circulation Research. The results hold promise for the design of a new drug class and for its potential use in combination with Viagra or beta blockers.

2-Sep-2009 9:00 AM EDT
Study Results Promise Faster Recovery from Life-Threatening Blood Cell Shortages
University of Rochester Medical Center

A key compound resupplies bone marrow with fast-acting stem cells that can more quickly rekindle blood cell production, according to a study published online today in the journal Blood. While the study was in mice, in the study authors say it has the potential to increase survival among patients with life-threatening blood cell shortages.

Released: 1-Sep-2009 2:00 PM EDT
Trial Reports on New Therapy That Prevents Heart Failure
University of Rochester Medical Center

Patients who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 34 percent reduction in their risk of death or heart failure when compared to patients receiving only an implanted cardiac defibrillator (ICD), according to a landmark study published online today in the New England Journal of Medicine and presented today at the European Society of Cardiology Congress (ESC) in Barcelona, Spain.

23-Jul-2009 3:15 PM EDT
Common Food Dye May Hold Promise in Treating Spinal Cord Injury
University of Rochester Medical Center

A study today in the Proceedings of the National Academy of Sciences shows that a common food additive that gives M&Ms and Gatorade their blue tint may offer promise for preventing the additional "“ and serious "“ secondary damage that immediately follows a traumatic injury to the spinal cord.

Released: 20-Jul-2009 3:45 PM EDT
Breast Cancer Drug Shows Promise Against Serious Infections
University of Rochester Medical Center

An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer.

Released: 16-Jul-2009 2:40 PM EDT
Genetic Source of Muscular Dystrophy Neutralized
University of Rochester Medical Center

Researchers at the University of Rochester Medical Center have found a way to block the genetic flaw at the heart of a common form of muscular dystrophy. The results of the study, which were published today in the journal Science, could pave the way for new therapies that essentially reverse the symptoms of the disease.

Released: 30-Apr-2009 10:00 AM EDT
Brain Protein Central to Both Parkinson's, Drug Addiction Identified
University of Rochester Medical Center

Scientists have identified a protein that appears not only to be central to the process that causes Parkinson's disease but could also play a role in muting the high from methamphetamine and other addictive drugs.

9-Apr-2009 9:00 AM EDT
Scientists Discover Way to Jumpstart Bone's Healing Process
University of Rochester Medical Center

An early study has found the osteoporosis drug teriparatide (Forteo) enabled aging patients confined to wheelchairs by non-healing fractures to walk and live independently again. The physicians involved are using the word "miraculous" to describe this stem cell-related work and its profound impact on the treatment of bone injuries.

30-Mar-2009 9:00 AM EDT
Rigorous Visual Training Teaches the Brain to See Again After Stroke
University of Rochester Medical Center

By doing a set of vigorous visual exercises on a computer every day for several months, patients who had gone partially blind as a result of suffering a stroke were able to regain some vision.

Released: 25-Mar-2009 1:10 PM EDT
Oxycodone Effective Against Shingles Pain
University of Rochester Medical Center

The painkiller oxycodone is effective at treating the acute pain of shingles, an illness that often causes severe pain which can become long-lasting and sometimes even permanent. Good treatment is crucial. It's possible that the pain of shingles is more likely to become a long-term problem if the pain is not adequately treated initially.

Released: 23-Mar-2009 12:55 PM EDT
Astrocytes Help Separate Man from Mouse
University of Rochester Medical Center

A type of brain cell that was long overlooked by researchers embodies one of very few ways in which the human brain differs fundamentally from that of a mouse or rat. Human astrocytes are bigger, faster, and much more complex than those in mice and rats.

Released: 12-Mar-2009 8:45 AM EDT
Weighing the Options after Life-Altering Stroke
University of Rochester Medical Center

Choosing to have aggressive brain surgery after suffering a severe stroke generally improves the patients' lives and allows them to live longer.

Released: 26-Feb-2009 2:35 PM EST
A Worm-and-Mouse Tale: B Cells Deserve More Respect
University of Rochester Medical Center

By studying how mice fight off infection by intestinal worms "“ a condition that affects more than 1 billion people worldwide "“ scientists have discovered that the immune system is more versatile than has long been thought. The work with worms is opening a new avenue of exploration in the search for treatments against autoimmune diseases like diabetes and asthma.

Released: 24-Feb-2009 1:00 PM EST
Updated Formula Measures Kidney Function More Accurately
University of Rochester Medical Center

Children with chronic kidney disorder are often subjected to radioactivity and a large number of blood draws when clinicians measure how well their kidneys function. This process is also time-consuming and costly. A new formula has been developed that accurately estimates the level at which children's kidneys are working using height, gender and measuring variables from just a small sample of blood.



close
0.1284